Internal Medicine, Gastroenterology · Chapel Hill, NC
NPI
1538246574
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
101 Manning Dr
Chapel Hill, NC, 27599
Phone (919) 966-4996
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
339 services
Medicare patients, 2024
155
Average age 68
Drug cost, 2024
$9.5M
1,306 prescriptions
Company payments, 2025
$17K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hans H Herfarth was code 99214 (office e&m - established), 90 times for 72 patients. In total Hans H Herfarth billed 339 services in 37 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 90 | 72 | $60.67 | $5,461 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 68 | 43 | $10.49 | $713 |
| 99215 Office E&M - Established | Office | 36 | 26 | $105.99 | $3,816 |
| 45380 Lower GI Endoscopy - Other | Office | 22 | 22 | $95.82 | $2,108 |
| 45385 Colonoscopy - Lesion Removal | Office | 13 | 13 | $195.61 | $2,543 |
By year: 2022 $26K for 287 services; 2023 $25K for 280 services; 2024 $23K for 339 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hans H Herfarth prescribed most often to Medicare patients was Stelara (Ustekinumab), with 121 prescriptions and refills. In total Hans H Herfarth wrote 1,306 Medicare prescriptions that cost $9.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 121 | 165 | 17 | $3.3M |
| Humira(Cf) Pen Adalimumab | 87 | 92 | Under 11 | $930K |
| Gattex Teduglutide | 73 | 73 | Under 11 | $3.8M |
| Cefdinir Generic | 69 | 152 | 30 | $5,092 |
| Loperamide Loperamide Hcl | 64 | 113 | 16 | $5,138 |
| Omeprazole Generic | 62 | 139 | 23 | $825 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 62 | 99 | 23 | $4,894 |
| Ciprofloxacin Hcl Generic | 36 | 71 | 13 | $1,054 |
| Prednisone Generic | 35 | 71 | 17 | $443 |
| Sodium Chloride 0.9 % Sodium Chloride | 35 | 35 | Under 11 | $307 |
| Magnesium Sulfate Generic | 34 | 34 | Under 11 | $598 |
| Skyrizi On-Body Risankizumab-Rzaa | 30 | 55 | Under 11 | $602K |
| Pantoprazole Sodium Generic | 22 | 50 | Under 11 | $324 |
| Celecoxib Generic | 22 | 26 | Under 11 | $1,227 |
| Opium Tincture Generic | 22 | 24 | Under 11 | $8,389 |
Brand drugs: 543 claims; generic drugs: 735 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hans H Herfarth $17K ($14K in general payments such as food, travel and fees and $3,575 for research) from 6 companies. The largest payer was Gilead Sciences, Inc. with $9,750.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.